Portola Pharmaceuticals Inc
Major Drugs - South San Francisco, CA, US
Portola Pharmaceuticals Inc Employees
Portola Pharmaceuticals Inc Details
We are focused on the discovery, development and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic conditions. The Company's first two commercialized products are Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo], marketed in Europe as Ondexxya® (andexanet alfa), and Bevyxxa® (betrixaban). The company also is advancing cerdulatinib, an investigational SYK/JAK inhibitor being developed for the treatment of hematologic cancers. We are continuing to explore new discoveries that impact how serious blood-related disorders are treated and expanding the potential impact of our existing portfolio of medicines.
Portola Pharmaceuticals Inc Technologies
Email Providers
Mimecast
Customer Relationship Management
Salesforce
Domain Name Services
Route 53
Email Delivery
Rackspace MailGun